OQS
PRQR icon

Occudo Quantitative Strategies’s ProQR Therapeutics PRQR Stock Holding History

Occudo Quantitative Strategies’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,053
Closed -$27.6K – 950
2024
Q1 		$27.6K Buy
+12,053
New +$25.8K ﹤0.01% 699
2023
Q2 		– Sell
-88,617
Closed -$189K – 1233
2023
Q1 		$189K Buy
+88,617
New +$271K 0.02% 762

Other funds holding PRQR

PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Occudo Quantitative Strategies's PRQR Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of ProQR Therapeutics (PRQR) in Q2 2024, closing a stake of 12,053 shares — an estimated $27.6K sold.

Occudo Quantitative Strategies first reported a position in PRQR in Q1 2023 and held it in 2 quarters. The position peaked at $189K in Q1 2023. 48 funds tracked by Wall St. Rank hold PRQR as of Q2 2024.

  • Occudo Quantitative Strategies reported no remaining ProQR Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 12,053 ProQR Therapeutics shares in Q2 2024, an estimated $27.6K.
  • Occudo Quantitative Strategies first reported a position in ProQR Therapeutics in Q1 2023 and held it in 2 quarters.
  • Occudo Quantitative Strategies's ProQR Therapeutics position peaked at $189K in Q1 2023.
  • 48 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.